Structural Immunology Section, Laboratory of Immunogenetics, NIAID, National Institutes of Health, Rockville, Maryland 20852, USA.
J Biol Chem. 2010 May 7;285(19):14806-14. doi: 10.1074/jbc.M109.079921. Epub 2010 Mar 5.
Transforming growth factor (TGF)-beta1, -beta2, and -beta3 are 25-kDa homodimeric polypeptides that play crucial nonoverlapping roles in embryogenesis, tissue development, carcinogenesis, and immune regulation. Here we report the 3.0-A resolution crystal structure of the ternary complex between human TGF-beta1 and the extracellular domains of its type I and type II receptors, TbetaRI and TbetaRII. The TGF-beta1 ternary complex structure is similar to previously reported TGF-beta3 complex except with a 10 degrees rotation in TbetaRI docking orientation. Quantitative binding studies showed distinct kinetics between the receptors and the isoforms of TGF-beta. TbetaRI showed significant binding to TGF-beta2 and TGF-beta3 but not TGF-beta1, and the binding to all three isoforms of TGF-beta was enhanced considerably in the presence of TbetaRII. The preference of TGF-beta2 to TbetaRI suggests a variation in its receptor recruitment in vivo. Although TGF-beta1 and TGF-beta3 bind and assemble their ternary complexes in a similar manner, their structural differences together with differences in the affinities and kinetics of their receptor binding may underlie their unique biological activities. Structural comparisons revealed that the receptor-ligand pairing in the TGF-beta superfamily is dictated by unique insertions, deletions, and disulfide bonds rather than amino acid conservation at the interface. The binding mode of TbetaRII on TGF-beta is unique to TGF-betas, whereas that of type II receptor for bone morphogenetic protein on bone morphogenetic protein appears common to all other cytokines in the superfamily. Further, extensive hydrogen bonds and salt bridges are present at the high affinity cytokine-receptor interfaces, whereas hydrophobic interactions dominate the low affinity receptor-ligand interfaces.
转化生长因子(TGF)-β1、-β2 和 -β3 是 25kDa 同源二聚体多肽,在胚胎发生、组织发育、致癌作用和免疫调节中发挥着至关重要的、互不重叠的作用。本文报道了人 TGF-β1 与Ⅰ型和Ⅱ型受体 TβRⅠ和 TβRⅡ的细胞外结构域的三元复合物的 3.0-A 分辨率晶体结构。TGF-β1 三元复合物的结构与之前报道的 TGF-β3 复合物相似,只是 TβRⅠ结合构象旋转了 10°。定量结合研究显示,受体与 TGF-β 异构体之间存在明显的动力学差异。TβRⅠ与 TGF-β2 和 TGF-β3 有显著结合,但与 TGF-β1 没有结合,而 TβRⅡ的存在显著增强了与所有三种 TGF-β 异构体的结合。TβRⅠ对 TGF-β2 的偏好表明其在体内募集受体的情况存在差异。尽管 TGF-β1 和 TGF-β3 以相似的方式结合并组装它们的三元复合物,但它们的结构差异以及受体结合的亲和力和动力学的差异可能是它们独特的生物学活性的基础。结构比较表明,TGF-β 超家族中的受体-配体配对由独特的插入、缺失和二硫键决定,而不是界面处的氨基酸保守性。TβRⅡ与 TGF-β 的结合模式是 TGF-β 所特有的,而骨形态发生蛋白Ⅱ型受体与骨形态发生蛋白的结合模式似乎在超家族的所有其他细胞因子中都很常见。此外,在高亲和力细胞因子-受体界面存在广泛的氢键和盐桥,而疏水性相互作用主导低亲和力受体-配体界面。